MONITORFORHIRE.COM AND OUTCOME SIGN PREFERRED PROVIDER AGREEMENT
Monitor For Hire will provide Outcome with access to more than 2,000 experienced monitors to support the company's project and data management flow for post-approval studies.
PHILADELPHIA – July 27, 2005 – Monitorforhire.com (Monitor For Hire) andOutcome have signed a preferred provider agreement. Monitor For Hire will provide Outcome with access to more than 2,000 experienced monitors tosupport the company's project and data management flow for post-approvalstudies. The relationship will help to globally implement Outcome'sstreamlined approaches to monitoring, targeted specifically to the uniquerequirements of Phase IV work.
"The pressure on pharmaceutical companies to develop reliable evidence inthe post-approval market is particularly strong," said Scott Freedman,president of Monitorforhire.com. "We are excited to help Outcome meet thisdemand by connecting its clients with pre-screened monitors in a variety ofspecialties."
Outcome is the leading provider of post-approval strategies andinformation-based solutions for the pharmaceutical and biotechnologyindustries. Backed by expertise and experience in over 30 therapeutic areas,Outcome has designed, developed and managed an industry leading number ofpost-approval studies, including more than 70 registries and many of thelargest and most well-recognized programs for disease outcomes andsafety/risk management.
"Working with Monitor For Hire to customize its service offering to theunique needs of the post-approval space, we enhance our ability to help ourclients demonstrate the effectiveness, safety and quality of theirproducts," said Richard Gliklich, MD, CEO of Outcome.
About Monitorforhire.com
Monitorforhire.com is the leading web-enabled resource management companyproviding qualified, regional independent clinical monitors to thepharmaceutical, biotechnology, medical device and contract researchindustries. The service allows registered sponsors to query the onlinesystem for pre-qualified, available monitors by therapeutic experience,indication experience and geographic location. Monitor For Hire has morethan 2000 monitors in 28 countries worldwide. Its growing client basecurrently consists of more than 330 clinical sponsors including majorpharmaceutical and biotechnology companies, academic institutions and CROs.Monitor For Hire has offices in Philadelphia, Pa. and San Diego, Calif. Formore information, please visit http://www.monitorforhire.com or call (610)862.0909 on the U.S. East Coast or (858) 4538030 on the West Coast.
About Outcome
Outcome is focused on helping organizations in life sciences and healthcaredevelop evidence, demonstrate effectiveness, manage safety and prove productvalue through registries, Phase IV studies, risk management and coverageunder protocol programs. An Outcome registry received the 2004 InnovationAward from the Department of Health and Human Services. With more than 1.5million patients enrolled in studies powered by Outcome and close to 3,000sites logging on to the Outcome system daily, the Company provides the mostwidely used solutions in the post-approval market. For more information,please visit www.outcome.com.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Phase III SELECT-GCA Trial Results Lead to FDA Approval of Rinvoq for Giant Cell Arteritis
April 30th 2025Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial demonstrating its efficacy in achieving sustained remission and reducing glucocorticoid exposure.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
